Metraipolis › archive › dc_090afb4166ef
From Oncolysis to Adaptive Immunity: Yellow Fever Virus 17D and Ruxolitinib Activate Antitumor Immune Responses in Pancreatic Cancer Models — Europe PMC PMID:42652146
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42652146
- DOI
- 10.3390/biomedicines14081763
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-17T03:08:44.243Z
- SHA-256 of the archived text
e585740c2eabbfc81a22c8e16005130f86da5a5626a7fbd2883be8e494759cb3- Stable URL of this page
https://metraipolis.com/documento/dc_090afb4166ef
How to cite
From Oncolysis to Adaptive Immunity: Yellow Fever Virus 17D and Ruxolitinib Activate Antitumor Immune Responses in Pancreatic Cancer Models — Europe PMC PMID:42652146 — Europe PMC (en), https://europepmc.org/article/MED/42652146 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_090afb4166ef (Metraipolis archive dc_090afb4166ef, sha256 e585740c2eabbfc81a22c8e16005130f86da5a5626a7fbd2883be8e494759cb3)
BibTeX
@misc{dc090afb4166ef,
title = {From Oncolysis to Adaptive Immunity: Yellow Fever Virus 17D and Ruxolitinib Activate Antitumor Immune Responses in Pancreatic Cancer Models — Europe PMC PMID:42652146},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42652146},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_090afb4166ef; sha256 e585740c2eabbfc81a22c8e16005130f86da5a5626a7fbd2883be8e494759cb3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42652146. Agents can read the archived copy with the MCP tool read_document.